In
the context of vaccine development and vaccine manufacturing these assays can provide a high value.
The module «Assay Development and Validation» will provide an insight into «state of the art» applications of SPR - technology in
the context of vaccine development.
Not exact matches
In order to facilitate access to these skills and capacities, and to promote collaborations in the European
vaccine landscape - aiming thereby to accelerate the
development of safe, effective and affordable
vaccines - the EC, in the
context of the Horizon 2020 Framework Programme, has recently funded «TRANSVAC2», a European
vaccine research and
development (R&D) infrastructure.
The European Commission (EC), in the
context of the Horizon 2020 Framework Programme, commits significant funding to TRANSVAC2, a European
vaccine research and
development (R&D) infrastructure.
TRANSVAC is a new infrastructure project - funded by the European Commission in the
context of Horizon 2020 - that aims to accelerate the
development of effective
vaccines urgently needed to address European and global health challenges with the ultimate goal to build an efficient and sustainable collaboration
of experts and facilities to catalyse
vaccine research in Europe.